One could speculate that tumor cells with an “aggressive” expression status, i.e. over-expression of EPHA1 and EPHA2 as well as down-regulation of EFNA1, possess a survival advantage under adverse conditions and thus, are capable of thriving in the foreign microenvironment of secondary sites. The gene discussed is EPHA1; the disease is neoplasm.